M&T Bank Corp Takeda Pharmaceutical CO LTD Transaction History

M&T Bank Corp

$28.9 Billion
Q3 2025

A detailed history of M&T Bank Corp transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, M&T Bank Corp holds 68,515 shares of TAK stock, worth $979,079. This represents 0.0% of its overall portfolio holdings.

Number of Shares

68,515

Previous 74,757 8.35%

Holding current value

$979,079

Previous $1.16 Million 13.16%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$13.6 - $15.52 $84,891 - $96,875	-6,242 Reduced 8.35%	68,515 $1 Million
Q2 2025 Aug 13, 2025	BUY	$13.71 - $15.46 $457,050 - $515,390	33,337 Added 80.49%	74,757 $1.16 Million
Q1 2025 Apr 30, 2025	BUY	$12.89 - $15.19 $37,458 - $44,142	2,906 Added 7.55%	41,420 $615,000
Q4 2024 Feb 06, 2025	SELL	$13.01 - $14.43 $55,643 - $61,717	-4,277 Reduced 10.0%	38,514 $509,000
Q3 2024 Nov 15, 2024	BUY	$13.0 - $15.08 $26,026 - $30,190	2,002 Added 4.91%	42,791 $608,000

Q2 2024 Jul 31, 2024	SELL	$12.6 - $13.67 $5,607 - $6,083	-445 Reduced 1.08%	40,789 $527,000
Q1 2024 May 07, 2024	BUY	$13.89 - $15.04 $101,535 - $109,942	7,310 Added 21.55%	41,234 $572,000
Q4 2023 Feb 06, 2024	SELL	$13.36 - $15.43 $141,669 - $163,619	-10,604 Reduced 23.81%	33,924 $484,000
Q3 2023 Nov 02, 2023	BUY	$15.03 - $16.32 $62,930 - $68,331	4,187 Added 10.38%	44,528 $688,000
Q2 2023 Aug 09, 2023	SELL	$15.57 - $17.11 $13,359 - $14,680	-858 Reduced 2.08%	40,341 $633,000
Q1 2023 May 11, 2023	BUY	$15.28 - $16.48 $217,984 - $235,103	14,266 Added 52.97%	41,199 $678,000
Q4 2022 Feb 13, 2023	BUY	$12.42 - $15.62 $102,601 - $129,036	8,261 Added 44.24%	26,933 $420,000
Q4 2022 Feb 13, 2023	BUY	$12.42 - $15.62 $231,906 - $291,656	18,672 New	18,672 $291,000
Q2 2022 Aug 05, 2022	BUY	$13.12 - $15.03 $137,287 - $157,273	10,464 New	10,464 $63,000
Q1 2021 May 06, 2021	SELL	$16.71 - $19.9 $176,273 - $209,925	-10,549 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$15.39 - $18.97 $119,872 - $147,757	-7,789 Reduced 42.47%	10,549 $192,000
Q3 2020 Nov 06, 2020	SELL	$17.1 - $19.19 $100,171 - $112,415	-5,858 Reduced 24.21%	18,338 $327,000
Q2 2020 Jul 29, 2020	SELL	$14.59 - $19.5 $59,352 - $79,326	-4,068 Reduced 14.39%	24,196 $434,000
Q1 2020 May 14, 2020	SELL	$13.02 - $20.31 $21,717 - $33,877	-1,668 Reduced 5.57%	28,264 $429,000
Q4 2019 Feb 07, 2020	BUY	$16.88 - $20.83 $65,764 - $81,153	3,896 Added 14.96%	29,932 $591,000
Q3 2019 Nov 12, 2019	SELL	$16.15 - $17.99 $24,547 - $27,344	-1,520 Reduced 5.52%	26,036 $448,000
Q2 2019 Aug 12, 2019	BUY	$16.58 - $20.49 $5,869 - $7,253	354 Added 1.3%	27,556 $488,000
Q1 2019 May 15, 2019	BUY	$16.7 - $21.52 $454,273 - $585,387	27,202 New	27,202 $554,000

Others Institutions Holding TAK

# of Institutions

383

Shares Held

80.6M

Call Options Held

1.67M

Put Options Held

276K

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $44.4B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.

Account